CCL Products Q2 FY27 Results (NSE: CCL)

· Analysis by Alpha Inflection

Signal: Growth decelerated

The read

The quarter marks a margin recovery after Q1FY27: consolidated gross margin expanded 532bps YoY to 37.9% and EBITDA margin rose to 18.0%, lifting PAT 29.0% to 13010.97 lakh, but revenue growth decelerated to 7.5% from 13.6% in Q1 and EPS growth lagged PAT at 21.6%.

CCL Products Q2 FY27 key financials
MetricValueYoYQoQ
Revenue₹1,210.76 Cr+7.5%+0.9%
EBIT₹176.84 Cr+10.7%
Net profit₹130.11 Cr+29.0%
EPS₹9.17+22.1%
EBIT margin18.0%

P&L walk

Revenue rose 7.5% YoY to 121076.24 lakh, gross margin expanded 532bps to 37.9% as raw-material intensity fell to 63.7%, EBITDA rose 9.4% to 21731.61 lakh, finance costs fell 20.4% to 2598.08 lakh and PAT rose 29.0% to 13010.97 lakh.

Segments

The group is materially stronger than the parent: consolidated revenue was 121076.24 lakh and PAT 13010.97 lakh versus standalone revenue of 68505.45 lakh and PAT of 4306.19 lakh; the filing identifies one consolidated reportable segment, so the earnings uplift sits in subsidiaries rather than a disclosed segment split.

Key positives

Key concerns

View original filing

Research and educational content only. Not investment advice.